Robert G. Mitchell, senior manager, contrast imaging solutions, explains how Bracco Diagnostics' acquisition of E-Z-EM further positions the company as a global leader in diagnostic imaging in radiology and cardiology. The merger allows for significant growth opportunities as E-Z-EM complements Bracco's comprehensive repertoire of diagnostic imaging agents. The synergies among both companies' product portfolios, complementary customer bases and technical expertise will strengthen Bracco Diagnostics' position in the evolving field of imaging informatics and patient management.
If you enjoy this content, please share it with a colleague
Related Content
June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...
May 14, 2025 — A comprehensive new study based on nationwide claims data from more than 11 million patients shows that ...
The issue of sustainability in healthcare has gained increasing focus over the past several years. During a 2022 plenary ...
April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...
April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...
Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...
Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...
Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...
Dec. 3, 2024 — During RSNA '24, GE HealthCare announced the 510(k) submission to the U.S. Food and Drug Administration ...
Dec. 2, 2024 — GE HealthCare has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing ...